AI주식인사이트AI Stock Insight
C

피플바이오

304840KOSDAQ의료용품 및 기타 의약 관련제품 제조업

47.8 / 100

Reference Date: 2026-04-13

Financial Score9.0 / 40
News Sentiment13.8 / 25
Momentum15.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, Revenue is on a declining trend. Surged 45.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

PeopleBio is a biotech company specializing in the development of biomarker-based diagnostic technologies for early detection of Alzheimer's disease. The company's SI-MDS technology enables the detection of oligomeric beta-amyloid through blood tests, offering a cost-effective and efficient alternative to existing methods like PET or lumbar puncture. With rising demand for dementia diagnostics due to aging populations, the market is expected to grow significantly.

Number of Employees

43people

Average Salary

60.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 13.514.0Point
PBR
4.00Industry Average 2.141.0Point

1.9x industry avg (risky)

ROE
-89.23Industry Average -3.613.5Point

24.7x industry avg (excellent)

Debt Ratio
255.28Industry Average 50.270.0Point

5.1x industry avg (risky)

Trend 2022~20240.5 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼8.0% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼2.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -112.5% (improving, 2yr)

Detailed News Sentiment

4 totalPositive 1Neutral 0Negative 0Average Sentiment Score 70

Detailed Momentum

52-week position3.0Point

52w lower range (27%)

Current 1,299Won52-week high 2,95552-week low 671
1-month return6.0Point

1m +44.98% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0
  • Neutral주주총회소집결의 (임시주주총회)2026-04-10
  • Neutral주주명부폐쇄기간또는기준일설정2026-04-02
  • Neutral정기주주총회결과2026-03-31
  • Neutral[기재정정]주요사항보고서(유형자산양수결정)2026-03-31
  • Neutral사업보고서제출기한연장신고서 (2025.12)2026-03-23